Why are triglyceride and ferritin levels elevated in hemophagocytic lymphohistiocytosis (HLH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Why Triglycerides and Ferritin Are Elevated in HLH

Triglycerides and ferritin are elevated in HLH because of the severe hyperinflammatory state driven by aberrantly activated macrophages and cytotoxic T cells, which leads to rampant cytokine secretion and dysregulated cellular metabolism. 1, 2

The Core Pathophysiology

HLH represents a severe hyperinflammatory syndrome characterized by an excessive but ineffective immune response. The fundamental defect involves impaired cytotoxic function of CD8 T cells and natural killer (NK) cells, which cannot properly eliminate activated immune cells. This results in:

  • Uncontrolled macrophage activation with persistent stimulation
  • Rampant cytokine secretion (cytokine storm)
  • Cellular hyperactivation that cannot be terminated 1, 2, 3

Mechanism of Hyperferritinemia

Ferritin elevation in HLH is directly linked to activated macrophages releasing massive amounts of ferritin into the serum. The proposed mechanism involves:

  • Macrophages are the primary source of serum ferritin secretion in HLH
  • The hyperinflammatory state causes massive upregulation of macrophage iron metabolism and ferritin release
  • Serum ferritin may serve a physiological dampening function by inhibiting lymphocyte activity and acting as an iron chelator to hinder pathogen growth 4

Clinical Significance of Ferritin Levels

Ferritin >10,000 μg/L is 90% sensitive and 96% specific for HLH 5. This extremely high threshold distinguishes HLH from other inflammatory conditions. Ferritin >6,000 μg/L is an independent prognostic factor for inferior survival (HR 2.47) 6.

Common pitfall: The HLH-2004 diagnostic criteria only require ferritin >500 μg/L, but this threshold is far too low to be specific. In practice, ferritin levels in HLH are typically >2,000 μg/L and often exceed 20,000 μg/L 7, 5.

Mechanism of Hypertriglyceridemia

Elevated triglycerides result from the cytokine-mediated metabolic dysfunction characteristic of HLH:

  • Cytokine storm impairs lipid metabolism through effects on lipoprotein lipase activity
  • Activated macrophages and the hyperinflammatory state disrupt normal triglyceride clearance
  • Hypertriglyceridemia correlates with coagulopathy (elevated INR), suggesting broader metabolic derangement 8

The hypertriglyceridemia is part of the broader metabolic dysfunction that includes hypofibrinogenemia and represents the systemic metabolic consequences of uncontrolled inflammation 3.

Diagnostic Integration

Both markers are part of the HLH-2004 diagnostic criteria:

  • Ferritin ≥500 μg/L (though >10,000 μg/L is more specific)
  • Hypertriglyceridemia (≥265 mg/dL) and/or hypofibrinogenemia (≤150 mg/dL)

These biochemical markers, combined with fever, cytopenias, splenomegaly, and hemophagocytosis, form the diagnostic framework 3, 6.

Clinical Caveat

Patients with elevated soluble IL-2 receptor (sIL2R) levels or hypertriglyceridemia may be at higher risk of bleeding complications due to associated coagulopathy. Monitor coagulation parameters closely in these patients 8.

The key takeaway: Both elevated triglycerides and ferritin are direct consequences of the uncontrolled macrophage activation and cytokine storm that define HLH pathophysiology, with ferritin levels being particularly useful for both diagnosis and prognosis.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.